OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Metformin has been well characterized in vitro as a substrate of liver-expressed organic cation transporters (OCTs). We investigated the gene expression and protein levels of OCT-1 and OCT-2 in adipose tissue and during adipogenesis and evaluated their possible role in metformin action on adipocytes. RESEARCH DESIGN AND METHODS: OCT1 and OCT2 gene expressions were analyzed in 118 adipose tissue samples (57 visceral and 61 subcutaneous depots) and during human preadipocyte differentiation. To test the possible role of OCT1 mediating the response of adipocytes to metformin, cotreatments with cimetidine (OCT blocker, 0.5 and 5 mmol/l) and metformin were made on human preadipocytes and subcutaneous adipose tissue (SAT). RESULTS: OCT1 gene was expressed in both subcutaneous and visceral adipose tissue. In both fat depots, OCT1 gene expression and protein levels were significantly increased in obese subjects. OCT1 gene expression in isolated preadipocytes significantly increased during differentiation in parallel to adipogenic genes. Metformin (5 mmol/l) decreased the expression of lipogenic genes and lipid droplets accumulation while increasing AMP-activated protein kinase (AMPK) activation, preventing differentiation of human preadipocytes. Cotreatment with cimetidine restored adipogenesis. Furthermore, metformin decreased IL-6 and MCP-1 gene expression in comparison with differentiated adipocytes. Metformin (0.1 and 1 mmol/l) decreased adipogenic and inflammatory genes in SAT. OCT2 gene expression was not detected in adipose tissue and was very small in isolated preadipocytes, disappearing during adipogenesis. CONCLUSIONS: OCT1 gene expression and protein levels are detectable in adipose tissue. Increased OCT1 gene expression in adipose tissue of obese subjects might contribute to increased metformin action in these subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The hepatic, intestinal and adipocytic uptake of metformin is primarily mediated through the OCT1”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Moreno-Navarrete et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
An, Z., Wang, H., Song, P., Zhang, M., Geng, X., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703701200 · Cited by 98
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 3×
“Metformin has been described to be more effective in obese subjects, and the degree of obesity has been found to constitute a strong predictor of metformin effects (3,4).”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“It has been reported that metformin binds to complex I of the mitochondrial respiratory chain, and this could in part explain how this drug acts (20).”
BackgroundBailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“Metformin (dimethylbiguanidine) is the most widely used drug for the treatment of type 2 diabetes (1,2).”
BackgroundKoepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967 · cited 2×
“OCT1 has been reported to be necessary for metabolic activities of metformin in liver cell lines (10).”
BackgroundAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“The activated form of AMPK switches on catabolic pathways while switching off ATP-consuming processes (19).”
BackgroundMetformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
Shu, Y., Brown, C., Castro, R., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E., Brett, C., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 477 · cited 1×
“Subjects carrying a single nucleotid polymorphism associated with a decrease in OCT1 gene expression also showed decreased metformin effects (4,10,16).”
Background
Cited by
Moreno-Navarrete, J. M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., & Fernández-Real, J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2749 · Cited by 788
“Human adipocyte differentiation Subcutaneous human preadipocytes (Zen-Bio Inc, Research Triangle Park, North Carolina) were cultured and differentiated as previously described (16).”
Self-citationBenefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
The SLC22 family with transporters of organic cations, anions and zwitterions
Koepsell, H. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.010 · Cited by 388
“…mammary gland, adrenal gland, eye, adipose tissue, and immune cells (Gilchrist and Alcorn, 2010; Koepsell et al., 2007; Minuesa et al., 2008; Moreno-Navarrete et al., 2011; Nishimura and Naito, 2005; Zhang et al., 2008b), and in various tumors (Gupta et al., 2011; Koepsell et al., 2007;…”
BackgroundDrug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
“In humans, OCT1, but not OCT2, expression was observed in subcutaneous and visceral adipose tissue, and OCT1 expression was increased in samples from obese subjects, suggesting that metformin action in these tissues may account for better metformin response in obese individuals (27).”
BackgroundOrganic Cation Transporters in Health and Disease
Koepsell, H. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 297
Molecular Mechanisms of Adipogenesis: The Anti-adipogenic Role of AMP-Activated Protein Kinase
Ahmad, B., Serpell, C. J., Fong, I. L., & Wong, E. H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00076 · Cited by 245
“Likewise, Moreno-Navarrete et al. (2011) showed reduced expression of key adipogenic factors such as FASN, ACC, PPARγ through activation of AMPK by metformin in human white preadipocytes differentiation.”
BackgroundProton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
Nies, A. T., Hofmann, U., Resch, C., Schaeffeler, E., Rius, M., & Schwab, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022163 · Cited by 184
“Since OCT1 and OCT3 are expressed in the plasma membrane of human hepatocytes, skeletal muscle cells, and adipocytes [10,12,13,31], an inhibition potential of OCT function by PPIs may abolish the glucose-lowering effect of metformin.”
BackgroundThe l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
Moreno-Navarrete, J. M., Catalán, V., Whyte, L., Díaz-Arteaga, A., Vázquez-Martínez, R., Rotellar, F., Guzmán, R., Gómez-Ambrosi, J., Pulido, M. R., Russell, W. R., et al. (2012) · Diabetes · doi:10.2337/db11-0649 · Cited by 160
“Samples of VAT and SAT were immediately transported to the laboratory (5–10 min), cut into small pieces, and processed as previously described (31).”
MethodSelf-citationChen, S. C., Brooks, R., Houskeeper, J., Bremner, S. K., Dunlop, J., Viollet, B., Logan, P. J., Salt, I. P., Ahmed, S. F., & Yarwood, S. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.011 · Cited by 127
“…in more differentiated cell lines, such as pre-osteoblasts (Jang et al., 2011, Kanazawa et al., 2008,Cortizo et al., 2006), pre-adipocytes (Moreno-Navarrete et al., 2011,Lee et al., 2012), myoblasts (Longnus et al., 2005,Kobashigawa et al., 2014,Fulco et al., 2008) and neuronal mouse cell…”
BackgroundMoreno‐Navarrete, J. M., Escoté, X., Ortega, F. J., Sérino, M., Campbell, M., Michalski, M., Laville, M., Xifra, G., Luche, É., Domingo, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3015-9 · Cited by 125
“Ex vivo experiments were performed using AT samples as previously described [24].”
MethodInfluentialSelf-citationDemaré, S., Kothari, A., Calcutt, N. A., & Fernyhough, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1847645 · Cited by 126
Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses
Casola, A. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000141 · Cited by 102
Metabolic Effects of Metformin in the Failing Heart
Dziubak, A., Wójcicka, G., Wojtak, A., & Bełtowski, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102869 · Cited by 104
“The reduction of plasma FFA level is associated with more efficient glucose uptake by the cells of peripheral tissues [38,39].”
BackgroundAntihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway
Cho, K., Chung, J. Y., Cho, S. K., Shin, H.-W., Jang, I.-J., Park, J.-W., Yu, K.-S., & Cho, J.-Y. (2015) · Scientific Reports · doi:10.1038/srep08145 · Cited by 81
Role of organic cation transporters in drug–drug interaction
Koepsell, H. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1069274 · Cited by 100
Bost, F., Sahra, I. B., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834d8155 · Cited by 100
“First of all, the presence of the organic cation transporter 1, the membrane metformin transporter, may modulate metformin response [47].”
BackgroundNeelakantan, H., Vance, V., Wetzel, M. D., Wang, H.-Y. L., McHardy, S. F., Finnerty, C. C., Hommel, J. D., & Watowich, S. J. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.11.007 · Cited by 85
Metformin in obesity, cancer and aging: addressing controversies
Berstein, L. M. (2012) · Aging · doi:10.18632/aging.100455 · Cited by 85
“Therefore, OCT1 may be a potential marker of metformin accumulation in the tissue [26].”
BackgroundRamachandran, S., Venugopal, A., Kutty, V. R., A, V., G, D., Chitrasree, V, Mullassari, A., Pratapchandran, N. S., Santosh, K. R., Pillai, M. R., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-38 · Cited by 82
Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_2 · Cited by 115
Self-citationSalani, B., Maffioli, S., Hamoudane, M., Parodi, A., Ravera, S., Passalacqua, M., Alama, A., Nhiri, M., Cordera, R., & Maggi, D. (2012) · The FASEB Journal · doi:10.1096/fj.11-192088 · Cited by 73
“necessary for metabolic activities of metformin (9).”
Cisternas, P., Zolezzi, J. M., Martínez, M., Torres, V. I., Wong, G. W., & Inestrosa, N. C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14608 · Cited by 80
Chen, D., Wang, Y., Wu, K., & Wang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061547 · Cited by 69
“Two studies examined 5 mM, and one study examined 4 mM of metformin, which significantly inhibited preadipocyte differentiation and lipid accumulation in 3T3-L1 or human preadipocytes [11,12,17].”
BackgroundMetformin prevents the pathological browning of subcutaneous white adipose tissue
Auger, C., Knuth, C. M., Abdullahi, A., Samadi, O., Parousis, A., & Jeschke, M. G. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.011 · Cited by 63
“The fact that adipose tissue expresses organic cation transporters (OCT1) renders it possible for hydrophilic positively-charged biguanides to enter this organ and induce biological effects [45].”
BackgroundHuman omental and subcutaneous adipose tissue exhibit specific lipidomic signatures
Jové, M., Moreno‐Navarrete, J. M., Pamplona, R., Ricart, W., Portero‐Otín, M., & Fernández‐Real, J. M. (2013) · The FASEB Journal · doi:10.1096/fj.13-234419 · Cited by 61
“, Research Triangle Park, NC, USA) were cultured as described previously (18).”
MethodSelf-citationModulation of Glucose Metabolism in Hippocampal Neurons by Adiponectin and Resistin
Cisternas, P., Martínez, M., Ahima, R. S., Wong, G. W., & Inestrosa, N. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1271-x · Cited by 63
Gu, Q., Gu, Y., Yang, H., & Shi, Q. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.241.13 · Cited by 51
“In addition, metformin can decrease adipogenic gene expression in subcutaneous adipose tissue explants (Moreno-Navarrete et al. 2011).”
Promising use of metformin in treating neurological disorders: biomarker-guided therapies
Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385286 · Cited by 53
Cisternas, P., Oliva, C. A., Torres, V. I., Barrera, D. P., & Inestrosa, N. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00295 · Cited by 45
“Experiments were conducted in triplicate and repeated at least three times (cat: KHO0651, Thermo Fisher Scientific Inc., United States) (Moreno-Navarrete et al., 2011; Stow et al., 2016).”
MethodLassaletta, A. D., Chu, L. M., Robich, M. P., Elmadhun, N. Y., Feng, J., Burgess, T. A., Laham, R. J., Sturek, M. S., & Sellke, F. W. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0243-y · Cited by 44
“It is not clear why the lipid profiles in the animals receiving a high-fat/cholesterol diet was made worse with the addition of metformin, as metformin has been shown to decrease the expression of lipogenic genes while increasing AMPK activation [21], as well as protect ischemic myocardium via the upregulation of Akt-…”
BackgroundMoreno‐Navarrete, J. M., Serrano, M., Sabater, M., Ortega, F. J., Sérino, M., Pueyo, N., Luche, É., Waget, A., Rodríguez‐Hermosa, J. I., Ricart, W., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.10.002 · Cited by 45
“Metformin, known to blunt adipogenesis as an AMPK inductor [25], or inflammatory mediators which induce insulin resistance, such as TNF-α and LPS-MCM [26,27], led to significantly decreased LTF gene expression during adipocyte differentiation.”
BackgroundSelf-citationChang, T., Tseng, H.-C., Liu, M.-W., Chang, Y., Hsieh, M.-L., & Chuang, L. (2016) · Scientific Reports · doi:10.1038/srep23403 · Cited by 48
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Yumiceba, V., López-Cortés, A., Pérez-Villa, A., Yumiseba, I., Guerrero, S., García-Cárdenas, J. M., Armendáriz-Castillo, I., Guevara-Ramírez, P., Leone, P. E., Zambrano, A. K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585130 · Cited by 40
“In contrast, high BMI is a consistent predictor of positive metformin response, as OCT proteins are expressed in adipose tissue (106).”
Hucke, A., & Ciarimboli, G. (2016) · Journal of clinical pharmacology · doi:10.1002/jcph.706 · Cited by 36
Arimany-Nardí, C., Koepsell, H., & Pastor‐Anglada, M. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.78 · Cited by 35
Lyu, Q., Wen, Y., He, B., Zhang, X., Chen, J., Sun, Y., Zhao, Y., Xu, L., Xiao, Q., & Deng, H. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166508 · Cited by 36
The human organic cation transporter OCT1 and its role as a target for drug responses
Brosseau, N., & Ramotar, D. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1670204 · Cited by 34
“High expression of OCT1 was associated with better response to metformin (Moreno-Navarrete et al. 2011), while patients with reduced transporter function, such as loss of both functional alleles, are intolerant to metformin by developing gastrointestinal side-effects causing discontinuation of…”
BackgroundClerbaux, L., Paini, A., Lumen, A., Osman‐Ponchet, H., Worth, A. P., & Fardel, O. (2019) · Environment International · doi:10.1016/j.envint.2019.03.003 · Cited by 40
Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_3 · Cited by 44
Self-citationPyla, R., Osman, I., Pichavaram, P., Hansen, P., & Segar, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.024 · Cited by 30
“In view of the likely increase in metformin uptake/action due to enhanced OCT-1 expression in adipose tissue in obese subjects [59], future studies should also determine how metformin uptake in perivascular adipose tissue [60] influences vascular tone in health and disease.”
Kristensen, J. M., Lillelund, C., Kjøbsted, R., Birk, J. B., Andersen, N. R., Nybo, L., Mellberg, K., Balendran, A., Richter, E. A., & Wojtaszewski, J. F. P. (2019) · Physiological Reports · doi:10.14814/phy2.14307 · Cited by 32
“Metformin effects have been shown to be positively related to BMI (Moreno-Navarrete et al., 2011; Shikata et al., 2007) and the subjects in the present study were lean (BMI of 22–24) compared with the diabetic patients (BMI of 31) in the study by Boyle et al. (2011), reporting increased AMPK…”
ResultInfluentialTargeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes
Ortega, F. J., Mercader, J. M., Moreno‐Navarrete, J. M., Sabater, M., Pueyo, N., Valdés, S., Ruiz, B., Luche, É., Naón, D., Ricart, W., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0979-8 · Cited by 26
Self-citationInflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression
Ortega, F. J., Moreno‐Navarrete, J. M., Mayas, D., Sérino, M., Rodríguez‐Hermosa, J. I., Ricart, W., Luche, É., Burcelin, R., Tinahones, F. J., Frühbeck, G., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.163 · Cited by 32
Self-citationHyršová, L., Smutný, T., Trejtnar, F., & Pávek, P. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1188936 · Cited by 26
Sam, W. J., Roza, O., Hon, Y. Y., Alfaro, R. M., Calis, K. A., Reynolds, J. C., & Yanovski, J. A. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.796 · Cited by 30
Wang, C.-P., Lehman, D. M., Lam, Y.-W. F., Kuhn, J. G., Mahalingam, D., Weitman, S. D., Lorenzo, C., Downs, J. R., Stuart, E. A., Hernández, J., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0425 · Cited by 24
“Notably, the expression of metformin organic cation transporter 1 (OCT1) is more pronounced in obese subjects (16, 17) who are at increased risk for metabolic syndrome and chronic inflammation.”
BackgroundPlasma membrane remodeling determines adipocyte expansion and mechanical adaptability
Aboy-Pardal, M. C. M., Guadamillas, M. C., Guerrero, C. R., Català-Montoro, M., Toledano-Donado, M., Terrés-Domínguez, S., Pavón, D. M., Jiménez-Jiménez, V., Jiménez‐Carretero, D., Zamai, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54224-y · Cited by 30
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
Cignarelli, A., Giorgino, F., & Vettor, R. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.796996 · Cited by 24
“Recently, Moreno-Navarrete et al. (2011) demonstrated that OCT1 gene expression and protein levels are detectable in both the subcutaneous and visceral adipose tissues, and this may underlie some effects of metformin on adipocytes.”
BackgroundHepatic exposure of metformin in patients with non‐alcoholic fatty liver disease
Sundelin, E. I. O., Gormsen, L. C., Heebøll, S., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Feddersen, S., Brøsen, K., Hamilton-Dutoit, S. J., Pedersen, S. B., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13962 · Cited by 22
Erickson, S. M., Fenno, S. L., Barzilai, N., Kuchel, G. A., Bartley, J. M., Justice, J. N., Buse, J. B., & Bramante, C. T. (2023) · Diabetes Care · doi:10.2337/dc22-2539 · Cited by 21
Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration
Wei, X.-L., Tao, M., Li, R.-H., Ge, S.-H., & Xiao, W. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2371 · Cited by 18
“Moreover, OCT1 is expressed on adipocytes, and its expression is notably elevated in obese individuals [32].”
Yang, L., Jia, X., Fang, D., Cheng, Y., Zhai, Z., Deng, W., Du, B., Lu, T., Wang, L., Yang, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115986 · Cited by 19
Mapping of biguanide transporters in human fat cells and their impact on lipolysis
Arner, P., Kulyté, A., Batchelor, K. W., Laurencikiene, J., Livingston, J. N., & Rydén, M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13395 · Cited by 16
“Interestingly, previous studies have suggested that OCT1 is involved in mediating AMPK activation and anti-inflammatory effects of metformin in human adipocytes.(14) In that study, the authors showed that SLC22A1 was expressed in human adipose tissue and in vitro differentiated adipocytes (commercially obtained from Z…”
BackgroundZhao, Z., Wang, C., Jia, J., Wang, Z., Li, L., Deng, X., Cai, Z., Yang, L., Wang, D., Ma, S., et al. (2022) · Adipocyte · doi:10.1080/21623945.2021.2013417 · Cited by 18
Schweighofer, N., Lerchbaum, E., Trummer, O., Theiler‐Schwetz, V., Pieber, T. R., & Obermayer-Pietsch, B. M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.223 · Cited by 17
Vazquez-Borrego, M. C., Fuentes-Fayos, A. C., Gahete, M. D., Castano, J. P., Kineman, R. D., & Luque, R. M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493448 · Cited by 15
Metformine et cancer : de nouvelles perspectives pour un ancien médicament
Loubière, C., Dirat, B., Tanti, J., & Bost, F. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.02.002 · Cited by 18
Adipose tissue TSH as a new modulator of human adipocyte mitochondrial function
Comas, F., Lluch, A., Sabater, M., Latorre, J., Ortega, F. J., Ricart, W., López, M., Fernández‐Real, J. M., & Moreno‐Navarrete, J. M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0203-1 · Cited by 17
Self-citationMoreno‐Navarrete, J. M., Ortega, F. J., Moreno, M., Xifra, G., Ricart, W., & Fernández‐Real, J. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.042 · Cited by 16
“Contrary to observations in mice (Moreno-Navarrete et al., 2011; Ohno et al., 2012), PRDM16 gene expression was significantly increased in human mature adipocytes and in human whole adipose tissue from the visceral fat depot.”
InfluentialSelf-citationThe Interactions of Herbal Compounds with Human Organic Anion/Cation Transporters
Chan, X. L. T. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000142 · Cited by 13
“Clinical significance: OCT1 have been extensively studied for their associations with the pharmacokinetics of anti-diabetic drug metformin as well as the pharmacological responses of front-line anticancer agent imatinib [94-107].”
BackgroundYang, Y., Luo, Y., Yi, S., Gao, Q., Gong, T., Feng, Y., Wu, D., Zheng, X., Wang, H., Zhang, G., et al. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199139 · Cited by 13
Serrano, M., Moreno, M., Ortega, F. J., Xifra, G., Ricart, W., Moreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1327 · Cited by 12
Self-citationEffect of Type 2 Diabetes Mellitus on the Pharmacokinetics of Metformin in Obese Pregnant Women
Baraldi, C. D. O., Moisés, E. C. D., Carvalho, T. M. D. J. P., Antunes, N. D. J., Lanchote, V. L., Duarte, G. G., & Cavalli, R. D. C. (2012) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0008-7 · Cited by 13
Chen, F., Li, D.-Y., Zhang, B., Sun, J., Sun, F., Ji, X., Qiu, J., Parker, R. B., Laizure, S. C., & Xu, J. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1497645 · Cited by 14
Role of OCT1 in hepatocellular carcinoma
Li, J., Yang, Z., & Tuo, B. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s212088 · Cited by 13
Molecular mechanism of anti‐adipogenic effect of vitexin in differentiating hMSCs
Gire, D., Acharya, J. D., Malik, S., Inamdar, S., & Ghaskadbi, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7300 · Cited by 11
Díaz, M., López‐Bermejo, A., Sánchez‐Infantes, D., Bassols, J., de Zegher, F., & Ibáñez, L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.075 · Cited by 11
Wang, C., Kuhn, J. G., Shah, D. P., Schmidt, S., Lam, Y.-W. F., MacCarthy, D., Tenner, L. L., & Ramírez, A. G. (2019) · Cancer Medicine · doi:10.1002/cam4.2142 · Cited by 10
Chen, P., Lu, M., Huang, M., Kao, C., Kuo, P., Chiu, C.-C., Lin, S., & Chen, C.-H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000386 · Cited by 10
“In the peripheral system, metformin decreases hepatic gluconeogenesis, increases peripheral glucose sensitivity,(11) prevents weight gain–related leptin incensement,(12) and decreases expression of lipogenic gene in adipocytes.(13) The limited number of studies on the genetic regulation of metformin response in clozap…”
BackgroundXiao, D., Zhang, S., Li, X., Yin, J., Gong, W., Zheng, Y., Xu, X., Lin, X., Ji, L., Liu, R., et al. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.95 · Cited by 8
Introduction to the Cellular Transport of Organic Cations
Ciarimboli, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_1 · Cited by 8
Ige, A. O., Ajayi, O. A., & Adewoye, E. O. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0104 · Cited by 7
Adipose TSHB in Humans and Serum TSH in Hypothyroid Rats Inform About Cellular Senescence
Moreno‐Navarrete, J. M., Liñares‐Pose, L., Sabater, M., Rial‐Pensado, E., Comas, F., Jové, M., Latorre, J., Ortega, F. J., Ricart, W., Portero‐Otín, M., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495170 · Cited by 5
Self-citationAhmed, F., Vranic, M., Hetty, S., Mathioudaki, A., Patsoukaki, V., Fanni, G., Pereira, M. J., & Eriksson, J. W. (2023) · Endocrinology · doi:10.1210/endocr/bqad172 · Cited by 7
“Our data on the mRNA levels of OCTs and catecholamine degradation enzymes are in accordance with protein levels found in the Human Protein Atlas (22) and previous studies (23–26).”
ResultNagahara, K., Dobashi, K., Ishikawa, T., Nakano, Y., Abe, Y., Tanaka, D., & Itabashi, K. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34835 · Cited by 5
Zhang, T., Calvier, E. A. M., Krekels, E. H. J., & Knibbe, C. A. J. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03885-5 · Cited by 4
“Conversely, in the case of drugs such as metformin [30], gentamicin [31, 32] and vancomycin [3, 33, 34], which exhibit lower serum protein binding, their increased CLr is likely due to the increased activity of organic cation transporter (OCT) 1 or 2 involved in their ATS [17, 35, 36].”
Jafri, F., Taylor, Z. L., González, D., & Shakhnovich, V. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2178897 · Cited by 4
Qiao, Q., Zhao, Z., Sun, Y., Wang, J., Li, X., Zhang, L., Yang, H., Zhang, N., Zhang, K., & Bai, Y. (2025) · Biomolecules · doi:10.3390/biom15050663 · Cited by 4
“In addition, José et al. [56] analyzed OCT1 and OCT2 gene expression in 118 human adipose tissue samples and found that increased OCT1 expression in obese individuals may enhance metformin action.”
Смирнов, Л. П. (2018) · Proceedings of the Karelian Research Centre of the Russian Academy of Sciences · doi:10.17076/eb866 · Cited by 2
Glycaemic Control and Protection of the Vasculature from Glucose Toxicity
Ding, H., & Chris, R. B. (2011) · InTech eBooks · doi:10.5772/24862 · Cited by 2
Endocrine and Metabolic Regulation of Transporters for Organic Cations
Aleksunes, L. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_6 · Cited by 2
Metformine et cancer : passé, présent, avenir
Loubière, C., Dirat, B., Tanti, J., & Bost, F. (2014) · Obésité · doi:10.1007/s11690-014-0418-9 · Cited by 3
Pharmacogenomics in Drug Metabolism Enzymes and Transporters
Lewis, J. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_110 · Cited by 3
Comparison of Swarm Optimization and Genetic Algorithm for Mobile Robot Navigation
Ćurković, P., Jerbić, B., & Stipanĉić, T. (2010) · InTech eBooks · doi:10.5772/8601 · Cited by 1
Pharmacogenomics in Drug Metabolism Enzymes and Transporters
Lewis, J. R. (2023) · Springer eBooks · doi:10.1007/978-3-030-73317-9_110-1 · Cited by 2
Felemban, A. H., Alshammari, G. M., Yagoub, A. E. A., Saleh, A. Y., & Yahya, M. A. (2024) · Nutrients · doi:10.3390/nu16183174 · Cited by 1
USING BIOPELLETS WITH METFORMIN IN THE EXPERIMENTAL METABOLIC SYNDROME
Волощук, Н. І., Zolotareva, V. G., Hara, A., Пашинська, О. С., Таран, И. В., Melnyk, A. V., & Denysiuk, V. O. (2024) · World of Medicine and Biology · doi:10.26724/2079-8334-2024-3-89-220-224 · Cited by 1
Proteomic profiling of metformin effects in 3T3‐L1 adipocytes by SILAC‐based quantification
Choi, S., Engelke, R., Goswami, N., & Schmidt, F. (2022) · PROTEOMICS · doi:10.1002/pmic.202100196 · Cited by 1
Metformine et aspirine : de « nouveaux » traitements du cancer ?
Arrondeau, J., & Bost, F. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2319-1 · Cited by 1
Berstein, L. M. (2012) · Obesity and metabolism · doi:10.14341/omet2012211-16
Metformin and Cancer: past, present, future
Loubière, C., Dirat, B., & Bost, F. (2014)
The Interactions of Herbal Compounds with Human Organic Anion/Cation
Chan, T., Xu, C., Ng, W. V., Zhu, L., & Zhou, F. (2014)
Purine Transport and Metabolism in Microvascular Endothelial Cells
Bone, D. B. J. (2011) · Scholarship@Western (Western University)
The Impact of Obesity on Proteins Involved in Drug Disposition
Abdussalam, A. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r33f4kt12
THE IMPACT OF OBESITY ON PROTEINS INVOLVED IN DRUG METABOLISM
Al-Agili, M. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r31n7z188
Acyl-ghrelin mediated lipid retention and inflammation within in vitro and ex vivo adipose depots
Churm, R. (2018) · Cronfa (Swansea University) · doi:10.23889/suthesis.40925
Chauhan, A., Naga, K. S., & Hasija, Y. (2021) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt51525.2021.9579679 · Cited by 1
The Study of the Transport Mechanism of Isorhynchophylline in Liver
Zhi-xian, H., Jin-yue, W., Wang, X., & Dong, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3867323
“Moreover, some studies indicated that OCTs are critical for the uptake and transport of drugs [19, 20], and the membrane transport proteins are obviously expressed in certain target tissues like liver, muscle, and adipose tissue [18, 21].”
BackgroundMiddelbeek, R. J. W., Yang, J., Nigro, P., James, B. T., Papadopoulos, D., Simpson, L. K., Park, J., Vamvini, M. T., Ho, L., Zhang, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.11.681273 · Cited by 1
“Individuals with T2D uniquely upregulated other TFs, such as POU2F1/OCT-1, a transcription factor that has been associated with increased metformin action in people with obesity 41 .”
Metadata
- Authors
- Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M.
- Affiliations
- From the Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomédica de Girona, CIBER Fisiopatología de la Obesidad y Nutrición CB06/03/010, Girona. Spain.
- Institut d'Investigació Biomèdica de Girona (ES)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-18
- Volume
- 60
- Issue
- 1
- Pages
- 168-176
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012168
- OpenAlex
- W2137586574
- Cited by
- 100
- References
- 22
- Citations by year
- 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 9 · 2018: 12 · 2017: 3 · 2016: 9 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 5
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- OCT1, organic cation transporters, metformin, adipocytes, adipose tissue, obesity, adipogenesis, preadipocyte differentiation, cimetidine, AMPK, lipogenesis, visceral adipose tissue, subcutaneous adipose tissue, interleukin-6, MCP-1, inflammation, drug transport
- MeSH terms
- Organic Cation Transporter 2, Acetyl-CoA Carboxylase, Acetyltransferases, Adenylate Kinase, Azo Compounds, Cell Differentiation, Coloring Agents, Gene Expression Regulation, Humans, Hypoglycemic Agents, Metformin, Obesity, RNA, Gastric Bypass, Gene Expression, Adipocytes, Organic Cation Transport Proteins, Organic Cation Transporter 1, PPAR gamma, Fatty Acid Synthase, Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.